Laurion Capital Management LP Amicus Therapeutics, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$9.2 - $23.86 $2.01 Million - $5.21 Million	-218,531 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$13.47 - $24.89 $2.71 Million - $5 Million	200,831 Added 1134.64%	218,531 $5.05 Million
Q3 2020 Nov 13, 2020	BUY	$12.89 - $15.89 $228,153 - $281,253	17,700 New	17,700 $250,000
Q1 2020 May 14, 2020	SELL	$6.63 - $11.16 $784,992 - $1.32 Million	-118,400 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$7.48 - $10.75 $885,632 - $1.27 Million	118,400 New	118,400 $1.15 Million
Q4 2018 Feb 14, 2019	SELL	$8.38 - $13.44 $315,314 - $505,706	-37,627 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$11.6 - $16.54 $436,473 - $622,350	37,627 New	37,627 $455,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.7B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.